What Algidol Ibu 400 Treats: Main Uses and Benefits

Algidol Ibu 400 is commonly used in areas where short-term symptomatic support is appropriate, focusing on symptoms that interfere with daily functioning across several key domains. As a Non-steroidal Anti-inflammatory Drug (NSAID), its therapeutic applications are relevant for easing pain, inflammation, and fever.

The medication is applicable across conditions presenting with acute episodes or recurrent manifestations, including managing discomfort from headache, muscular aches, dental pain, menstrual cramps, and symptoms related to acute illness like fever and body aches during a cold or flu. It is also relevant for easing the pain and stiffness associated with inflammatory conditions such as arthritis.

“It is commonly applied because it offers supportive relief that helps patients cope more steadily with difficult, transient episodes of discomfort.”

This support helps address symptom clusters that create noticeable functional strain, assisting in the maintenance of comfort and contributing to improved day-to-day comfort when symptoms are more noticeable.

---

Quick Fact: Relief for Key Symptom Clusters
Algidol Ibu 400 contributes to easing the overall symptom burden in three areas: physical discomfort, inflammatory irritation, and elevated body temperature.

Regulatory References

1. NIH MedlinePlus overview

Eligibility Map: Official Regulatory Information

This information reflects the population eligibility and non-eligibility status for Algidol Ibu 400 (Ibuprofen 400 mg) as mandated by regulatory authorities.

Populations Allowed	Populations Contraindicated (Must Not Use)
Adults and Adolescents (ge 12 years or ge 40 kg)	Known hypersensitivity to ibuprofen, aspirin, or other NSAIDs
Short-term use during lactation (breastfeeding)	Active or recurrent peptic ulcer/haemorrhage (two or more distinct episodes)
Patients with mild-to-moderate renal or hepatic impairment (with caution)	Severe heart failure (NYHA Class IV), severe renal/hepatic failure

---

Age- and Condition-Specific Restrictions

• Children under 12 years of age are generally not recommended for the 400 mg strength, as lower doses are more appropriate [Source 2.1].
• Use in the third trimester of pregnancy is contraindicated; use in the first and second trimesters is discouraged unless clearly necessary [Source 2.4].
• Older adults must use the lowest effective dose for the shortest duration due to increased risk of adverse reactions, particularly GI bleeding [Source 1.1].
• The medicine is contraindicated following a history of GI bleeding or perforation related to previous NSAID therapy or in the setting of severe dehydration [Source 1.1].

Algidol Ibu 400 is subject to several documented interaction patterns as described in regulatory prescribing information. Co-administration is strictly prohibited with other Non-Steroidal Anti-inflammatory Drugs, including COX-2 selective inhibitors, and high-dose Acetylsalicylic Acid (Aspirin), as these combinations significantly increase the risk of gastrointestinal ulceration and bleeding. Furthermore, concurrent consumption of Alcohol is strongly discouraged as it compounds the risk of stomach hemorrhage.

A primary concern involves pharmacokinetic interactions where Algidol Ibu 400 reduces the elimination of certain co-administered medicines. Specifically, regulatory documents state that use with Lithium decreases its renal clearance, which can lead to dangerously elevated plasma levels. Similarly, the medicine increases the plasma concentration of Methotrexate by inhibiting its renal tubular secretion, elevating the risk of toxicity.

Pharmacodynamic interactions involve functional conflicts or additive risks. Co-use with Anticoagulants, Antiplatelet agents, or Selective Serotonin Reuptake Inhibitors increases the overall risk of bleeding. The medicine may also diminish the desired therapeutic effect of Antihypertensives, such as ACE inhibitors and Diuretics. To mitigate interference with the anti-platelet action of low-dose Aspirin, a single 400 mg dose of Ibuprofen requires a specific timing separation: it must be taken at least 8 hours before or 30 minutes after the immediate-release Aspirin dose. Interaction severity is officially noted to be heightened in elderly patients and those with pre-existing renal impairment.

The Mechanism of Ibuprofen: Enzyme Inhibition

Algidol Ibu 400 acts via its active ingredient, Ibuprofen, which functions as a non-selective, reversible inhibitor of the Cyclooxygenase (COX) enzymes, specifically targeting both COX-1 and COX-2 isoforms. The molecule competitively binds to the active site of these enzymes, thereby blocking the rate-limiting step in the conversion of arachidonic acid into prostanoids, such as Prostaglandin E2 (PGE2).

Pharmacodynamic Consequences

This molecular action modulates the core inflammatory cascade and alters central signaling. Peripherally, the reduction in PGE2 concentration prevents the hyper-sensitization of nociceptors at sites where tissue damage has occurred. Centrally, Ibuprofen’s presence in the hypothalamus also reduces local PGE2 synthesis. This activity facilitates the reset of the body’s thermal set-point, which triggers physiological heat dissipation mechanisms, while the peripheral effect modulates pain signal transmission.

General Principles of Administration

Algidol Ibu 400 is an oral solid preparation that must be administered via the oral route. The guiding principle of use is to utilize the lowest effective dose for the shortest duration necessary to control symptoms. The tablet or capsule should be swallowed whole with a full glass of fluid.

Dosing Schedules and Frequency

For acute, mild to moderate discomfort, an individual dose is 400 mg. Doses for acute use are generally taken every four to six hours as needed. The total dose for non-prescription use must not exceed 1200 mg within a 24-hour period. For certain chronic inflammatory conditions, prescribed regimens may utilize a higher maximum total daily dose, which is divided and administered multiple times daily.

Contextual Use and Duration

The medication is taken with food or immediately after a meal, a principle intended for patients with a sensitive stomach. Non-prescription use for pain or fever is typically limited to a short course, often not exceeding 10 days for pain or 3 days for fever without professional guidance. Population-specific administration rules indicate that older adults and patients with mild to moderate renal or hepatic impairment should utilize the lowest effective dose for the shortest possible duration.

Recent Clinical Evidence

This section summarizes key research that has evaluated the effects and pharmacological properties of ibuprofen 400 mg, the active ingredient in Algidol Ibu 400.

Clinical Trial Findings for Pain and Fever

Clinical trials have investigated the use of ibuprofen 400 mg for the management of mild to moderate pain, including headache, dental pain, and musculoskeletal pain, as well as for fever reduction. Evidence from studies in acute pain models suggests that a measurable change in pain scores may be observed within 24 to 48 minutes after administration.

Research explores the concept of an analgesic ceiling, noting that doses above 400 mg may not necessarily be associated with a clinically significant increase in pain-relieving effect.

Mechanism of Action

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID). Its action involves the non-selective, reversible inhibition of cyclooxygenase (COX) enzymes—specifically COX-1 and COX-2. This inhibition reduces the body's synthesis of prostaglandins, which are compounds involved in signaling pain, inflammation, and fever.

Long-Term Safety Profile

Long-term research has contributed to understanding the safety profile of the drug. While short-term, low-dose use is generally well tolerated, studies indicate that prolonged use or higher doses may be associated with an increased risk of serious gastrointestinal adverse events (such as ulceration or bleeding) and cardiovascular thrombotic events (including heart attack or stroke). These risks must be considered when evaluating the drug's use.

Key Studies & References

1. Non-steroidal anti-inflammatory drugs (NSAIDs): mechanism of action and clinical implications

Common questions about Algidol Ibu 400 (FAQ)

---

Q: Is Algidol Ibu 400 different from regular ibuprofen?

Brand-name products like Algidol Ibu 400 contain the exact same active ingredient, ibuprofen, and are required to work in the same way as generic versions. The differences are typically found in the inactive ingredients (like fillers or colors) used by the manufacturer, as well as the product’s packaging and cost.

---

Q: Does Algidol Ibu 400 require a prescription?

The active ingredient in this medication, ibuprofen 400 mg, is generally available for non-prescription (Over-the-Counter or OTC) use in most areas. OTC use is specifically intended for the short-term relief of mild to moderate pain and fever.

---

Q: How long does the effect of Algidol Ibu 400 usually last?

Official pharmacokinetic data indicates that the half-life of the active ingredient, ibuprofen, is approximately 1.8 to 2.0 hours. The half-life describes the time it takes for half of the medication to be eliminated from the body.

---

Q: Are there any known issues with taking Algidol Ibu 400 for a short period?

Regulatory documents indicate that common side effects, such as headache or stomach upset, can occur even when the drug is taken for a short duration. Serious side effects, including cardiovascular or gastrointestinal events, are advised to be considered, as they may also begin early in treatment.

---

Q: Is Algidol Ibu 400 considered a strong or a mild medicine?

The medicine is typically described in clinical contexts as effective for the management of mild to moderate pain and fever. This functional description positions it separately from prescription medications reserved for the management of severe pain.

---

Q: Why might a doctor prefer Algidol Ibu 400 over another pain reliever?

Clinical literature often classifies the active ingredient, ibuprofen, as a commonly used non-opioid analgesic due to its established anti-inflammatory, analgesic, and antipyretic properties. It is frequently utilized in the management of acute pain due to its established mechanism of action and risk profile.

---

Q: Does Algidol Ibu 400 have a potential for dependence?

Official information indicates that the active ingredient, ibuprofen, is not an opioid and is generally not associated with substance use disorder. Therefore, it does not cause physical tolerance or withdrawal symptoms.

---

Q: What are the inactive ingredients in Algidol Ibu 400?

Official drug labels are required to list all active and inactive ingredients. While the exact list varies by the manufacturer and the dosage form, inactive ingredients commonly include components such as binders, fillers (like microcrystalline cellulose), and coloring agents.

---

Q: Do official documents mention any effects of Algidol Ibu 400 on sleep?

Although not listed as a common reaction, the active ingredient, ibuprofen, is associated with occasional central nervous system effects, such as dizziness or nervousness. In some regulatory safety reports, drowsiness has been noted as a potential side effect.

---

Q: What is the consensus in research on Algidol Ibu 400 for chronic pain?

Regulatory guidance for non-prescription use limits the duration to a short course for pain. For managing chronic conditions, such as certain types of arthritis, the medicine is used under professional supervision, and long-term monitoring is required due to the increased risk of cardiovascular and gastrointestinal adverse events.

---

Q: Can Algidol Ibu 400 affect the results of any common medical tests?

Official prescribing information notes that treatment may be associated with borderline elevations of certain liver function tests. Furthermore, during long-term use, monitoring of complete blood counts and renal function tests is necessary, indicating the medicine's potential effect on these markers.

---

Q: What is the recommended approach for managing a common side effect of Algidol Ibu 400?

For patients who may experience stomach upset, which is a common side effect, official labeling describes that taking the medication either with food or with milk may be an option.

---

Q: Does Algidol Ibu 400 contain any components derived from animals?

The active ingredient, ibuprofen, is a synthetic chemical compound. While the inactive ingredients in a tablet formulation are often non-animal derived, if the product is a capsule, the capsule shell may contain gelatin, which is typically derived from animal sources.

---

Q: Do official labels for Algidol Ibu 400 include a Black Box Warning?

Official FDA-regulated labels for the active ingredient, ibuprofen, contain prominent warnings. These warnings specifically address the risk of serious cardiovascular thrombotic events (like heart attack or stroke) and serious gastrointestinal events (like bleeding and ulceration).

---

Q: Are there specific official guidelines for discontinuing Algidol Ibu 400 use?

There are no generalized cessation protocols (such as tapering) described for non-prescription use. Regulatory advice indicates that use should be discontinued immediately if symptoms worsen or if signs of serious adverse effects, such as gastrointestinal bleeding, are observed.

---

Q: Are there any common foods that should be avoided when taking Algidol Ibu 400?

Official product information advises that you can take this medication with food or milk, which may help lessen stomach upset. While no common non-alcoholic foods are listed as strictly prohibited, concurrent consumption of alcohol is strongly discouraged as it significantly increases the risk of gastrointestinal bleeding.

---

Q: Are there any warnings about driving or operating machinery while using Algidol Ibu 400?

Regulatory documents caution users to be aware of potential side effects, such as dizziness or lightheadedness. Official warnings indicate that due to the potential for central nervous system effects, such as dizziness, individuals should avoid driving or operating hazardous machinery if they experience these symptoms.

---

Q: Are there specific studies about Algidol Ibu 400 in older adults?

Regulatory summaries do not typically cite specific, dedicated clinical trials for the 400 mg dose in older adults. However, official guidance requires increased caution and monitoring for this population due to their known greater risk for cardiovascular and gastrointestinal adverse events.

---

Q: Are there differences in how Algidol Ibu 400 is absorbed based on when it is taken?

Regulatory data indicates that the active ingredient is typically absorbed and reaches its highest levels in the blood within one to two hours. Studies have shown that the absorption of the active ingredient is not affected by co-administration with certain antacids.

---

Q: Are there any interactions between Algidol Ibu 400 and common psychiatric medications?

Official documents specifically note a potential interaction with Selective Serotonin Reuptake Inhibitors (SSRIs) and some other antidepressants. This interaction is noted because the combination may increase the overall risk of bleeding.

---

Official Storage and Disposal Requirements

Storage and disposal instructions for ibuprofen 400 mg are strictly defined by regulatory labeling to maintain product stability and ensure public safety.

Storage and Handling Requirement	Official Regulatory Statement
Temperature and Environment	The product must be stored below 25 C or 30 C and protected from moisture. Do not freeze.
Packaging	Keep the medicine in its original container or packaging. If in a bottle, the container must be kept tightly closed.
Child Safety	It is mandatory to keep the product out of the sight and reach of children.

For disposal, any unused or expired Algidol Ibu 400 must be handled according to local requirements. Regulatory documents instruct that the medicine should not be discarded via household waste or wastewater (flushing).